Exact Mass: 382.1715
Exact Mass Matches: 382.1715
Found 238 metabolites which its exact mass value is equals to given mass value 382.1715
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
7alpha,8alpha-Dihydroxycalonectrin
7alpha,8alpha-Dihydroxycalonectrin is a mycotoxin from Fusarium culmorum and Fusarium roseum. Mycotoxin from Fusarium culmorum and Fusarium roseum
4,8-Diacetyl-T2-tetrol
4,8-Diacetyl-T2-tetrol is a mycotoxin produced by Fusarium sporotrichioides, Fusarium tricinctum and Haemophilus parainfluenzae. Mycotoxin production by Fusarium sporotrichioides, Fusarium tricinctum and Haemophilus parainfluenzae D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
Cyclocalopin B
Cyclocalopin B is found in mushrooms. Cyclocalopin B is isolated from Boletus calopus and other Boletus species. Isolated from Boletus calopus and other Boletus subspecies Cyclocalopin B is found in mushrooms.
Ibuprofen glucuronide
Ibuprofen glucuronide (CAS: 115075-59-7) is a natural human metabolite of ibuprofen generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs, or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.
Eletriptan
Eletriptan is only found in individuals that have used or taken this drug. It is a second generation triptan drug developed by Pfizer Inc for the treatment of migraine headaches. [Wikipedia]Eletriptan binds with high affinity to 5-HT1B, 5-HT1D and 5-HT1F receptors, has modest affinity for 5-HT1A, 5-HT1E, 5-HT2B and 5-HT7 receptors, and little or no affinity for 5-HT2A, 5-HT2C, 5-HT3, 5-HT4, 5-HT5A and 5-HT6 receptors. Eletriptan has no significant affinity or pharmacological activity at adrenergic alpha1, alpha2, or beta; dopaminergic D1 or D2; muscarinic; or opioid receptors. Two theories have been proposed to explain the efficacy of 5-HT receptor agonists in migraine. One theory suggests that activation of 5-HT1 receptors located on intracranial blood vessels, including those on the arteriovenous anastomoses, leads to vasoconstriction, which is correlated with the relief of migraine headache. The other hypothesis suggests that activation of 5-HT1 receptors on sensory nerve endings in the trigeminal system results in the inhibition of pro-inflammatory neuropeptide release. N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist
(E)-4-(1,2,3,6-Tetrahydro-2,6-dioxo-1,3-dipropyl-9H-purin-8-yl)cinnamic acid
2-Cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid
Ibuprofen Acyl-beta-D-glucuronide
Neosolaniol
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
3-Hydroxy-2-phenyl-N-(1-phenylpropyl)quinoline-4-carboxamide
[5aR-(5aalpha,6alpha,8alpha,9beta,9abeta,9balpha)]-8-(Acetyloxy)-3-[(acetyloxy)methyl]-5,5a,6,7,8,9,9a,9b-octahydro-6,9-dihydroxy-5a,9-dimethylnaphtho[1,2-b]furan-2(4H)-one
(3alpha,4beta,7alpha)12,13-Epoxy-trichothec-9-ene-3,4,7,15-tetrol 4,15-diacetate
ADB-FUBINACA
(6aR,9R,9aR)-9-Acetyl-3-[(1E,3E,5S)-3,5-dimethyl-1,3-heptadien-1-yl]-6a-methyl-9,9a-dihydro-6H-furo[2,3-H]isochromene-6,8(6aH)-dione
1-(2,3-dibenzimidazol-2-ylpropyl)-2-methoxybenzene
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.921 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.919 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.915 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.913
4-(3,4,8,9-Tetrahydro-8-isopropenyl-5-methoxy-6-methyl-2H-furo[2,3-h]-1-benzopyran-3-yl)-3-methoxyphenol
2,6-Dihydroxy-4-[(E)-5-hydroxy-3,7-dimethylocta-2,7-dienyloxy] benzophenone|2,6-dihydroxy-4-[(E)-5-hydroxy-3,7-dimethylocta-2,7-dienyloxy]benzophenone
5-methoxy-2,2-dimethyl-6-(2-methyl-1-oxo-2-butenyl)-10-propyl-2H,8H-benzo[1,2-b,3,4-b]dipyran-8-one|5-Methoxy-2,2-dimethyl-6-(2-methyl-1-oxo-2-butenyl)-10-propyl-2H,8H-benzo[1,2-b:3,4-b]dipyran-8-one|5-Methoxy-2,2-dimethyl-6-<(E)-2-methylbut-2-enoyl>-10-propyl-2H,8H-benzo<1,2-b:3,4-b>dipyran-8-one|GUT-70
6-acetyl-3-(3,5-dimethyl-1E,3E-heptadienyl)-9R-hydroxy-8a(R)-methyl-7H-furo[2,3-g]-2-benzopyran-7-one|rotiorinol A
6alpha-phenylacetoxy-4beta,5alpha-epoxygermacra-1(10)E,11-dien-8alpha,12-olide
3-(2-Hydroxy-7-methyl-3-methylene-6-octenyl)-2,4,6-trihydroxybenzophenone
(S)-2,3-dihydro-5,7-dimethoxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one|mepuberin
(1S,2S,4R,5S,6R,7S,8R,9R,10S)-2,6-diacetoxy-4,9-dihydroxyguai-11(13)-en-8,12-olide
yadanziolide V
A quassinoid isolated from he ethanol extract of the stem of Brucea mollis.
3alpha-acetoxy-5beta-(4-acetoxytigloyloxy)-7-hydroxycarvotanacetone
3alpha-acetoxy-5beta-(4-hydroxytigloyloxy)-7-acetoxycarvotanacetone
hyperinakin|phenyl(2,4,6-trihydroxy-3-((3-methyl-3-(4-methylpent-3-enyl)oxiran-2-yl)methyl)phenyl)methanone
(1R*,4R*,8S*,10R*)-1,4-epoxy-1,13-dimethoxy-8-hydroxy-10-acetoxygermacra-5E,7(11)-dien-6,12-olide
2alpha,5alpha-diacetoxy-10beta-hydroperoxy-germacra-3Z,11(13)dien-12,8alpha-olide
(E)-3-(6-hydroxy-3,7-dimethylocta-2,7-dienyl)-2,4,6-trihydroxybenzophenone
(+)-8-acetyl-13-O-ethyl-piptocarphol|1alpha,10alpha-dihydroxy-8alpha-acetoxy-13-ethoxyhirsutinolide
(1R*,4R*,8S*,10R*)-1,4-epoxy-1,13-dimethoxy-8-acetoxy-10-hydroxygermacra-5E,7(11)-dien-6,12-olide
4beta-(hydroxymethyl)-3beta,4alpha-dihydroxy-8alpha-[(S)-3-hydroxy-2-methylenepropionyloxy]-1alphaH,5alphaH,6betaH,7alphaH,11betaH,11alpha-methylguaia-10(14)-en-6,12-olide|ramosine
(9aR)-9a-Methyl-3-octanoyl-6-trans-propenyl-9aH-furo[3,2-g]isochromen-2,9-dion|(9aR)-9a-methyl-3-octanoyl-6-trans-propenyl-9aH-furo[3,2-g]isochromene-2,9-dione|(R-(E))-9a-methyl-3-(1-oxooctyl)-6-(1-propenyl)-2H-furo[3,2-g][2]benzopyran-2,9(9aH)-dione|Monascorubrin
1-beta-hydroxy-8-O-(4-hydroxybutyroyl)-onopordic acid
3beta,4beta,5-trimethoxy-6,6-dimethyl-2H-pyrano-(2,3:7,6)-flavan|3beta-methoxyxuulanin|3??-Methoxyxuulanin
MLS000876965-01!(6aR,9R,9aR)-9-acetyl-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-6a-methyl-9,9a-dihydrofuro[2,3-h]isochromene-6,8-dione
C23H26O5_6H-Furo[2,3-h]-2-benzopyran-6,8(6aH)-dione, 9-acetyl-3-[(1E,3E,5S)-3,5-dimethyl-1,3-heptadien-1-yl]-9,9a-dihydro-6a-methyl-, (6aR,9R,9aR)
1-(alpha-methyl-4-(2-methylpropyl)benzeneacetate) b-D-Glucopyranuronic acid
Eletriptan
N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist
7,8-Dihydroxycalonectrin
Cyclocalopin B
Valepotriate
[4-[4-(2,2-dimethylpropanoyloxy)benzoyl]phenyl] 2,2-dimethylpropanoate
Talnetant
Talnetant (SB 223412) is a selective, competitive, brain-permeable NK3 receptor antagonist with a Ki of 1.4 nM in hNK-3-CHO cells. Talnetant is 100-fold more selective for hNK-3 relative to the hNK-2 receptor and has no affinity for hNK-1. Talnetant can be used in schizophrenia-related studies[1][2][3].
N-Ethyl-4-{[5-(Methoxycarbamoyl)-2-Methylphenyl]amino}-5-Methylpyrrolo[2,1-F][1,2,4]triazine-6-Carboxamide
(E)-4-(1,2,3,6-Tetrahydro-2,6-dioxo-1,3-dipropyl-9H-purin-8-yl)cinnamic acid
Rotiorinol A
An azaphilone that is 9,9a-dihydro-2H-furo[3,2-g]isochromen-2-one substituted by an acetyl group at position 3, a hydroxy group at position 9, a 3,5-dimethylhepta-1,3-dien-1-yl group at position 6 and a methyl group at position 9a. It has been isolated from Chaetomium cupreum and exhibits antifungal activity.
2-[1-(1H-benzimidazol-2-yl)-3-(2-methoxyphenyl)propan-2-yl]-1H-benzimidazole
Ethyl 5-cyano-6-[4-(4-methoxyphenyl)piperazino]-2-oxo-1,2-dihydro-3-pyridinecarboxylate
4-[4-(4-methylbenzoyl)piperazino]-3-nitrobenzenecarbaldehyde O-methyloxime
2-{5-[Amino(iminio)methyl]-6-fluoro-1H-benzimidazol-2-YL}-6-[(2-methylcyclohexyl)oxy]benzenolate
2,5-Bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol
2-O-(3-Amidinophenyl)-5-O-(4-amidinophenyl}-1,4:3,6-dianhydro-D-sorbitol
2,5-O,O-Bis-{4,4-amidinophenyl}-1,4:3,6-dianhydro-D-sorbitol
2-O-(4-Amidinophenyl)-5-O-(3-amidinophenyl)-1,4:3,6-dianhydro-D-sorbitol
8-Hydroxydiacetoxyscirpenol
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
[(1R,2R,3S,4R,10R)-10-acetyloxy-3,4-dihydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-2-yl]methyl acetate
1-(alpha-Methyl-4-(2-methylpropyl)benzeneacetate)-beta-D-glucopyranuronic acid
N3,N6-bis(2,5-dimethoxyphenyl)pyridazine-3,6-diamine
N-[5-[6-(3-chloroanilino)-4-pyrimidinyl]-2-pyridinyl]-N,N-dimethylpropane-1,3-diamine
2-[3-[(4-methylphenyl)methyl]-7-oxo-6-triazolo[4,5-d]pyrimidinyl]-N-(2-oxolanylmethyl)acetamide
1-[5-[[Anilino(oxo)methyl]amino]-1,3-dimethyl-2-oxo-4-imidazolidinyl]-3-phenylurea
5-[[4-(Diethylamino)anilino]methylidene]-1-(2-furanylmethyl)-1,3-diazinane-2,4,6-trione
1-Ethyl-4-[[methyl-[[3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]methyl]amino]methyl]-2-pyrrolidinone
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-pyrimidinylmethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-pyrimidinylmethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-pyrimidinylmethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
[(1R,5S)-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-pyrazin-2-ylmethanone
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-pyrimidinylmethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-pyrimidinylmethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-pyrimidinylmethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-pyrimidinylmethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-pyrimidinylmethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) octanoate
(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) heptanoate
(1-Butanoyloxy-3-phosphonooxypropan-2-yl) nonanoate
(1-Acetyloxy-3-phosphonooxypropan-2-yl) undecanoate
(1-Phosphonooxy-3-propanoyloxypropan-2-yl) decanoate
2,5,7,8-Tetramethyl-2-[2-[(1H-benzimidazol-2-yl)thio]ethyl]chroman-6-ol
4,8-Diacetyl-T2-tetrol
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
Roxindole (hydrochloride)
Roxindole hydrochloride (EMD 38362), an indot-alkyl-pipenidine, is a potent agonist at dopamine autoreceptors, with an affinity for the D2-like subtype in the low nanomolar range. Roxindole can be used for the research of positive and negative schizophrenic symptoms. Roxindole is a 5-HT1A agonist and 5-HT uptake inhibitor with high affinity for 5-HT1A (IC50=0.9 nM). Antipsychotic and antidepressant activities[1][2][3].
9a-methyl-3-octanoyl-6-(prop-1-en-1-yl)furo[3,2-g]isochromene-2,9-dione
(6ar)-9-acetyl-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-6a-methyl-9h,9ah-furo[2,3-h]isochromene-6,8-dione
4-(ethoxymethyl)-12-hydroxy-8,12-dimethyl-3,9-dioxo-2,14-dioxatricyclo[6.5.1.0¹,⁵]tetradec-4-en-6-yl acetate
5-methoxy-2,2-dimethyl-6-(2-methylbut-2-enoyl)-10-propylpyrano[2,3-h]chromen-8-one
(3as,4r,4as,5r,7s,7as,8s,9r,9ar)-7-(acetyloxy)-5,9-dihydroxy-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-4-yl acetate
(1'r,2s,2'r,3'r,7'r,10'r,11's)-11'-(acetyloxy)-3',10'-dihydroxy-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-2'-ylmethyl acetate
(1r,2s,4r,7r,8r,9s,10r,11r,12s)-7,8,10,11-tetrahydroxy-2,9,12-trimethyl-2-[(2r)-3-methyl-5-oxo-2h-furan-2-yl]-5-oxatricyclo[6.3.1.0⁴,¹²]dodecan-6-one
4'-(acetyloxy)-10',11'-dihydroxy-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-2'-ylmethyl acetate
(1s,2r,11s,15s,16s,17s)-2,7,15,17-tetrahydroxy-5-methoxy-11-methyl-10,19-dioxatricyclo[14.2.1.0³,⁸]nonadeca-3,5,7-trien-9-one
(1s,5r,6r)-5-(acetyloxy)-3-(hydroxymethyl)-6-isopropyl-2-oxocyclohex-3-en-1-yl 4-(acetyloxy)-2-methylbut-2-enoate
2-[3-hydroxy-2-(3-methylbut-2-en-1-yl)benzoyl]-4-(3-methylbut-2-en-1-yl)benzene-1,3,5-triol
7-benzoyl-2-(2-hydroxypropan-2-yl)-5-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzofuran-4,6-diol
2,6-dihydroxy-4-[(e)-5-hydroxy-3,7-dimethyl-octa-2,7-dienyloxy] benzophenone
{"Ingredient_id": "HBIN004880","Ingredient_name": "2,6-dihydroxy-4-[(e)-5-hydroxy-3,7-dimethyl-octa-2,7-dienyloxy] benzophenone","Alias": "NA","Ingredient_formula": "C23H26O5","Ingredient_Smile": "CC(=C)CC(CC(=CCOC1=CC(=C(C(=C1)O)C(=O)C2=CC=CC=C2)O)C)O","Ingredient_weight": "382.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5907","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11338042","DrugBank_id": "NA"}